Sequencing ALK inhibitors: Alectinib in crizotinib-resistant patients, a phase 2 trial by Shaw et al.

Laura Mezquita, Benjamin Besse

Résultats de recherche: Contribution à un journal › Editorial

6 Citations (Scopus)

Accès au document

@article{e8bb3ba1f9b54023963815f13eba9dbe,

title = "Sequencing ALK inhibitors: Alectinib in crizotinib-resistant patients, a phase 2 trial by Shaw et al.",

author = "Laura Mezquita and Benjamin Besse",

year = "2016",

month = jan,

day = "1",

doi = "10.21037/jtd.2016.11.76",

language = "English",

volume = "8",

pages = "2997--3002",

journal = "Journal of Thoracic Disease",

issn = "2072-1439",

number = "11",

}

TY - JOUR

T1 - Sequencing ALK inhibitors

T2 - Alectinib in crizotinib-resistant patients, a phase 2 trial by Shaw et al.

AU - Mezquita, Laura

AU - Besse, Benjamin

PY - 2016/1/1

Y1 - 2016/1/1

UR - http://www.scopus.com/inward/record.url?scp=85010424602&partnerID=8YFLogxK

U2 - 10.21037/jtd.2016.11.76

DO - 10.21037/jtd.2016.11.76

M3 - Editorial

AN - SCOPUS:85010424602

SN - 2072-1439

VL - 8

SP - 2997

EP - 3002

JO - Journal of Thoracic Disease

JF - Journal of Thoracic Disease

IS - 11

ER -